GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (BOM:500674) » Definitions » EV-to-Revenue

Sanofi India (BOM:500674) EV-to-Revenue : 7.09 (As of May. 27, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Sanofi India EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sanofi India's enterprise value is ₹199,669 Mil. Sanofi India's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹28,175 Mil. Therefore, Sanofi India's EV-to-Revenue for today is 7.09.

The historical rank and industry rank for Sanofi India's EV-to-Revenue or its related term are showing as below:

BOM:500674' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.11   Med: 4.59   Max: 7.33
Current: 7.09

During the past 13 years, the highest EV-to-Revenue of Sanofi India was 7.33. The lowest was 3.11. And the median was 4.59.

BOM:500674's EV-to-Revenue is ranked worse than
83.77% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs BOM:500674: 7.09

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Sanofi India's stock price is ₹8832.75. Sanofi India's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1,223.38. Therefore, Sanofi India's PS Ratio for today is 7.22.


Sanofi India EV-to-Revenue Historical Data

The historical data trend for Sanofi India's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi India EV-to-Revenue Chart

Sanofi India Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 6.27 5.70 4.58 6.46

Sanofi India Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.58 4.80 5.60 5.96 6.46

Competitive Comparison of Sanofi India's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Sanofi India's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi India's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi India's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sanofi India's EV-to-Revenue falls into.



Sanofi India EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sanofi India's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=199668.726/28175
=7.09

Sanofi India's current Enterprise Value is ₹199,669 Mil.
Sanofi India's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹28,175 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanofi India  (BOM:500674) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sanofi India's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=8832.75/1223.377
=7.22

Sanofi India's share price for today is ₹8832.75.
Sanofi India's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,223.38.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanofi India EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sanofi India's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi India (BOM:500674) Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth strategy.

Sanofi India (BOM:500674) Headlines

No Headlines